What edge pharma sp. z o.o. does

Edge Pharma Sp. z o.o. is a privately held Polish pharmaceutical consulting and sourcing company, founded in 2019 and headquartered in Warsaw, with a complementary China Division operating as a regional hub. The firm targets pharmaceutical companies needing cross-border execution between the European Union and Chinese markets, serving two primary customer segments: foreign pharmaceutical companies seeking entry into China and Chinese enterprises seeking entry into the EU. Its core commercial offering is the sourcing and distribution of high-purity Active Pharmaceutical Ingredients (APIs) and specialty raw materials, supplemented by a nine-module consulting suite covering regulatory affairs and EMA/NMPA compliance, QA/QC and GMP quality management, market access and pricing, strategy and commercialization, supply chain and logistics, R&D and product development lifecycle, technology transfer, and CEP/ASMF/DMF dossier management.

The company operates an asset-light, human-delivered model with no proprietary technology platform disclosed; instead, value is generated through a curated network of audited contract manufacturers, laboratories, R&D centers, universities, and research institutes that enable GMP-compliant sourcing and quality verification. The team is composed of pharmacists, regulatory specialists, and international trade experts with bicultural EU-China operating experience, including Managing Partners Karol Tyrala (EU Division) and Peter Yu (China Division), CSO Maciej Swiatkiewicz, Procurement Director Diego Shen, Logistics Director Cherry Zhang, and business development lead Serena Zhao. Edge Pharma's stated differentiators are dual local market presence, rigorous GMP auditing of Asian manufacturers, end-to-end dossier and registration support, transparent batch-level traceability, tailored custom API sourcing, and end-to-end logistics management.

The business model is professional services revenue, with publicly disclosed pricing of $50/hour for remote support and $80/hour for on-site consulting — the only public pricing signal, which appears to represent entry-level or tactical support rather than enterprise engagement pricing. The go-to-market motion is consultative, sales-led, and relationship-driven, relying on direct business development, industry events, a professional website, and a LinkedIn company page rather than digital marketing at scale. The company is founder/management-owned with no disclosed external investors, funding rounds, M&A activity, or patents/trademarks. The website exhibits template placeholder artifacts, suggesting limited investment in digital infrastructure, which is a notable maturity signal given the firm's otherwise enterprise-targeted positioning.

Name

edge pharma sp. z o.o.

Legal name

EDGE Pharma Sp. z o.o.

Website

https://edgepharma.eu

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Edge Pharma is a Warsaw-based pharmaceutical consulting and sourcing firm that bridges EU and Chinese pharma markets, offering API sourcing plus regulatory, QA/QC, market access, supply chain, and technology-transfer consulting to enterprise pharma clients on both sides of the corridor.

Ownership category

akta.pro rank

Product category

Pharmaceutical Sourcing & Consulting

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Chemical and Allied Products Merchant Wholesalers (4246)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industries

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE)

Keywords

• API sourcing services
• Pharmaceutical consulting
• Regulatory affairs services
• GMP compliance auditing
• Pharmaceutical distribution

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Pharmaceutical Consulting Services: Professional services revenue derived from consulting engagements including regulatory affairs, QA/QC and GMP quality management systems, market access and pricing consulting, strategy and commercialization consulting, supply chain and logistics consulting, and R&D and product development lifecycle support. Services are priced on an hourly basis for remote and in-home/business support.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Edge Pharma Sp. z o.o. supplies pharmaceutical ingredients (APIs) and provides sourcing, regulatory affairs, QA/QC, GMP compliance, market access, strategy, supply chain, and technology-transfer consulting services that bridge the EU and China pharmaceutical markets for cross-border trade.

Product overview

Edge Pharma is a specialized consulting company that operates as a unified service platform bridging European and Asian pharmaceutical markets. The company's core offering combines API sourcing and distribution with a comprehensive suite of consulting services, including Regulatory Affairs & Compliance Consulting, QA/QC & GMP Quality Management Systems, Market Access and Pricing Consulting, Strategy and Commercialization Consulting, Supply Chain and Logistics Consulting, R&D & Product Development Lifecycle, and Technology Transfer Services. These services are delivered as integrated modules supporting the full product lifecycle from sourcing through regulatory compliance and market access, with the Pharmaceutical Products (API Sourcing) serving as the primary commercial offering supplemented by the consulting service modules.

Differentiator

Problem solved

Functional benefit

Products and services

• API Sourcing and Pharmaceutical Product Supply Cross-border supply of pharmaceutical active pharmaceutical ingredients (APIs) and finished dosage forms bridging EU and China markets, for pharmaceutical companies seeking qualified ingredient suppliers.
• Regulatory Affairs and Compliance Consulting Consulting covering CEP, ASMF, and DMF dossier management, EMA and NMPA submissions, and regulatory strategy for pharmaceutical companies navigating EU-China registration pathways.
• QA/QC and GMP Quality Management Systems Consulting Quality assurance and quality control consulting, GMP auditing, and quality management system implementation for pharmaceutical manufacturers and suppliers.
• Market Access and Pricing Consulting Market access strategy, pricing analysis, reimbursement advisory, and commercial launch support for pharmaceutical products entering EU or Chinese markets.
• Pharmaceutical Strategy and Commercialization Consulting Strategic advisory and commercial planning services supporting pharmaceutical companies on cross-border growth, partnerships, and market entry between EU and China.
• Supply Chain and Logistics Consulting Pharmaceutical supply chain optimization, logistics management, and distribution channel advisory for cross-border EU-China pharmaceutical trade.
• R&D and Product Development Lifecycle Support Research and development advisory and product development lifecycle support for pharmaceutical companies developing and launching products across EU and China markets.
• Technology Transfer Consulting Cross-border pharmaceutical technology transfer consulting supporting the transfer of manufacturing processes, analytical methods, and documentation between EU and Chinese facilities.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered supporting and core.

• Research InstitutessupportingOthersCooperates with scientific and applied research organizations that support early-stage innovation, technical evaluation, and specialized pharmaceutical or biotechnological expertise. These partnerships contribute to understanding technical requirements and development pathways.
• LaboratoriessupportingOthersNetwork includes analytical, quality control, and specialized testing laboratories that help verify product parameters, support documentation, and ensure alignment with regulatory expectations.
• Contract ManufacturerscoreStrategic or Co-development PartnerWorks with contract manufacturing organizations and production partners capable of supporting scale-up, process development, commercial manufacturing, and technology transfer. Integral to API sourcing and supply chain operations.
• Pharmaceutical CompaniescoreStrategic or Co-development PartnerEngages with established pharmaceutical companies to support strategic sourcing, market access, development cooperation, and long-term supply chain resilience. Primary client relationships in the pharmaceutical sector.
• UniversitiessupportingOthersAcademic partners contribute scientific knowledge, research capabilities, and access to emerging innovation across biotechnology, chemistry, pharmacy, and life sciences.
• R&D CenterssupportingStrategic or Co-development PartnerR&D centers play an important role in product development, formulation work, process optimization, validation, and the transition from laboratory concepts to industrial application.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• WuXi AppTec: China-headquartered CRO/CDMO offering API manufacturing, regulatory support, and global market access services — directly overlapping with Edge Pharma's EU-China API sourcing and regulatory consulting model at a much larger scale.
• Shanghai ChemPartner: China-based CRO/CDMO providing API sourcing, medicinal chemistry, and technology transfer services between China and Western pharma — a direct comparable in the cross-border pharma services niche.
• PharmaZell (formerly C2 Pharma / Novasep): European API manufacturer and supplier serving global pharma with regulatory dossiers (CEP/DMF) — directly comparable to Edge Pharma's API sourcing + dossier management offering.
• Novasep: European CDMO specializing in API synthesis and purification with regulatory support — overlaps with Edge Pharma's API sourcing and technology transfer services targeting pharma companies.
• Aenova Group: European CDMO and API developer serving pharma companies with regulatory and supply chain services — comparable scope in EU-based API sourcing and dossier support.
• Recipharm: European CDMO offering API supply, technology transfer, and regulatory support to pharma clients — directly comparable end-to-end service scope.
• Alcami Corporation: US-headquartered pharma services firm offering API development, analytical services, and regulatory support — overlaps with Edge Pharma's QA/QC and dossier management work.

Broad incumbents

• Eurofins Scientific: Global leader in pharma testing, GMP auditing, and regulatory consulting; competes for the same QA/QC and dossier management mandates that Edge Pharma targets across the EU and Asia.
• IQVIA: Full-service clinical, regulatory, and market access consulting powerhouse that bundles the EMA/NMPA regulatory and market access services Edge Pharma offers, alongside much deeper enterprise reach.

Emerging players

• Sai Life Sciences: India-based CRO/CDMO providing API/intermediate sourcing and regulatory services to global pharma — competes for similar cross-border sourcing mandates with a comparable mid-sized specialist profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/edge-pharma-sp-z-o-o

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about edge pharma sp. z o.o.